Potential roles of D-serine and serine racemase in experimental temporal lobe epilepsy

Journal of Neuroscience Research

Volumn 88, Issue 11, 2010, Pages 2469-2482

  Ryu, H J ^a   Kim, J E ^a   Yeo, S I ^a   Kim, D S ^b   Kwon, O S ^c   Choi, S Y ^a   Kang, T C ^a  

^a Hallym University   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

Astrocytes; D serine; Epilepsy; Microglia; Serine racemase

Indexed keywords

DEXTRO SERINE; DIAZEPAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; SERINE DERIVATIVE; SERINE RACEMASE; UNCLASSIFIED DRUG; GLIAL FIBRILLARY ACIDIC PROTEIN; ISOMERASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; EPILEPTIC STATE; GLIA; HIPPOCAMPUS; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; TEMPORAL LOBE EPILEPSY; UPREGULATION; ANIMAL; CELL MOTION; CYTOLOGY; ELECTROPHYSIOLOGY; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SEIZURE; SPRAGUE DAWLEY RAT;

ANIMALS; ASTROCYTES; CELL MOVEMENT; ELECTROPHYSIOLOGY; EPILEPSY, TEMPORAL LOBE; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; NEUROGLIA; RACEMASES AND EPIMERASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES; SERINE;

EID: 77955411061     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22415     Document Type: Article

References (50)

1. Andre V, Ferrandon A, Marescaux C, Nehlig A. 2001. Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res 47:99-117.
2. Bahn JH, Kwon OS, Joo HM, Ho Jang S, Park J, Hwang IK, Kang TC, Won MH, Yil Kwon H, Kwok F, Kim HB, Cho SW, Choi SY. 2002. Immunohistochemical studies of brain pyridoxine-5′-phosphate oxidase. Brain Res 925:159-168.
3. Baranano DE, Ferris CD, Snyder SH. 2001. Atypical neural messengers. Trends Neurosci 24:99-106.
4. Baumgart F, Rodríguez-Crespo I. 2008. D-amino acids in the brain: the biochemistry of brain serine racemase. FEBS J 275:3538-3545.
5. Bignami A, Raju T, Dahl D. 1982. Localization of vimentin, the nonspecific intermediate filament protein, in embryonal glia and in early differentiating neurons, in vivo and in vitro immunofluorescence study of the rat embryo with vimentin and neurofilament antisera. Dev Biol 91:286-295.
6. Choi SY, Churchich JE, Zaiden E, Kwok F. 1987. Brain pyridoxine-5- phosphate oxidase. Modulation of its catalytic activity by reaction with pyridoxal 5-phosphate and analogs. J Biol Chem 262:12013-12017.
7. Chouinard ML, Gaitan D, Wood PL. 1993. Presence of the N-methyl-D-aspartate-associated glycine receptor agonist, D-serine, in human temporal cortex: comparison of normal, Parkinson, and Alzheimer tissues. J Neurochem 61:1561-1564.
8. Coyle JT, Tsai G, Goff DC. 2002. Ionotropic glutamate receptors as therapeutic targets in schizophrenia. Curr Drug Targets CNS Neurol Disord 1:183-189.
9. Crump FT, Dillman KS, Craig AM. 2001. cAMP-dependent protein kinase mediates activity-regulated synaptic targeting of NMDA receptors. J Neurosci 21:5079-5088.
10. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. 1995. Epidemiology of status epilepticus. J Clin Neurophysiol 12:316-325.
11. Ehlers MD, Tingley WG, Huganir RL. 1995. Regulated subcellular distribution of the NR1 subunit of the NMDA receptor. Science 269:1734-1737.
12. Ehlers MD, Zhang S, Bernhadt JP, Huganir RL. 1996. Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit. Cell 84:745-755.
13. El-Hassar L, Esclapez M, Bernard C. 2007. Hyperexcitability of the CA1 hippocampal region during epileptogenesis. Epilepsia 5:131-139. (Pubitemid 47512214)
14. Eliasson C, Sahlgren C, Berthold CH, Stakeberg J, Celis JE, Betsholt C, Eriksson JE, Pekny M. 1999. Intermediate filament protein partnership in astrocytes. J Biol Chem 274:23996-24006.
15. Fields RD, Stevens-Graham B. 2002. New insights into neuron-glia communication. Science 298:556-562.
16. Fong DK, Rao A, Crump FT, Craig AM. 2002. Rapid synaptic remodeling by protein kinase C: reciprocal translocation of NMDA receptors and calcium/calmodulin-dependent kinase II. J Neurosci 22:2153-2164. (Pubitemid 35386515)
17. Fujikawa DG. 1995. Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia 36:186-195.
18. o in juvenile rat hippocampal area CA1. Neuroreport 9:2583-2587.
19. Hertz L. 2008. Bioenergetics of cerebral ischemia: a cellular perspective. Neuropharmacology 55:289-309.
20. Hisatsune C, Umemori H, Inoue T, Michikawa T, Kohda K, Mikoshiba K, Yamamoto T. 1997. Phosphorylation-dependent regulation of Nmethyl-D-aspartate receptors by calmodulin. J Biol Chem 272:20805-20810.
21. Kang TC, Kim DS, Kwak SE, Kim JE, Won MH, Kim DW, Choi SY, Kwon OS. 2006. Epileptogenic roles of astroglial death and regeneration in the dentate gyrus of experimental temporal lobe epilepsy. Glia 54:258-271.
22. Kim DS, Kim JE, Kwak SE, Choi KC, Kim DW, Kwon OS, Choi SY, Kang TC. 2008. Spatiotemporal characteristics of astroglial death in the rat hippocampo-entorhinal complex following pilocarpine-induced status epilepticus. J Comp Neurol 511:581-598.
23. Kim JE, Kwak SE, Choi SY, Kang TC. 2008. Region-specific alterations in astroglial TWIK-related acid-sensitive K1-1 channel immunoreactivity in the rat hippocampal complex following pilocarpine-induced status epilepticus. J Comp Neurol 510:463-474.
24. Kleckner NW, Dingledine R. 1988. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241:835-837.
25. Kobayashi M, Buckmaster PS. 2003. Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J Neurosci 23:2440-2452. (Pubitemid 36368933)
26. Kwak SE, Kim JE, Kim DS, Won MH, Lee HJ, Choi SY, Kwon OS, Kim JS, Kang TC. 2006. Differential paired-pulse responses between the CA1 region and the dentate gyrus are related to altered CLC-2 immunoreactivity in the pilocarpine-induced rat epilepsy model. Brain Res 1115:162-168.
27. Kwak SE, Kim JE, Kim DW, Kwon OS, Choi SY, Kang TC. 2009. Enhanced pyridoxal 50-phosphate synthetic enzyme immunoreactivities do not contribute to GABAergic inhibition in the rat hippocampus following pilocarpine-induced status epilepticus. Neuroscience 159:1108-1118.
28. Marrif H, Juurlink BH. 1999. Astrocytes respond to hypoxia by increasing glycolytic capacity. J Neurosci Res 57:255-260.
29. Mayer ML, Vyklicky L Jr, Westbrook GL. 1989. Modulation of excitatory amino acid receptors by group IIB metal cations in cultured mouse hippocampal neurones. J Physiol 415:329-350.
30. Mothet JP, Parent AT, Wolosker H, Brady RO Jr, Linden DJ, Ferris CD, Rogawski MA, Snyder SH. 2000. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 97:4926-4931.
31. Mothet JP, Pollegioni L, Ouanounou G, Martineau M, Fosier P, Baux G. 2005. Glutamate receptors activation triggers a calcium- and SNARE protein-dependent release of the gliotransmitter d-serine. Proc Natl Acad Sci U S A 102:5606-5611.
32. Panizzutti R, De Miranda J, Ribeiro CS, Engelender S, Wolosker H. 2001. A new strategy to decrease N-methyl-D-aspartate (NMDA) receptor coactivation: inhibition of D-serine synthesis by converting serine racemase into an eliminase. Proc Natl Acad Sci U S A 98:5294-5299. (Pubitemid 32397122)
33. Racine RJ. 1972. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281-294.
34. Rice AC, DeLorenzo RJ. 1998. NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Res 782:240-247.
35. Rossetti AO, Logroscino G, Liaudet L, Ruffieux C, Ribordy V, Schaller MD, Despland PA, Oddo M. 2007. Status epilepticus: an independent outcome predictor after cerebral anoxia. Neurology 69:255-260.
36. Sasabe J, Chiba T, Yamada M, Okamoto K, Nishimoto I, Matsuoka M, Aiso S. 2007. D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis. EMBO J 26:4149-4159.
37. Schell MJ, Molliver ME, Snyder SH. 1995. D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci U S A 92:3948-3952.
38. 13C NMR spectroscopy: incorporation of more label into lactate than into glutamine demonstrates the importance of the tricarboxylic acid cycle. J Neurochem 61:1179-1182.
39. Stevens ER, Esguerra M, Kim PM, Newman EA, Snyder SH, Zahs KR, Miller RF. 2003. D-serine and serine racemase are present in the vertebrate retina and contribute to the physiological activation of NMDA receptors. Proc Natl Acad Sci U S A 100:6789-6794.
40. Stewart LS, Persinger MA. 2001. Ketamine prevents learning impairment when administered immediately after status epilepticus onset. Epilepsy Behav 2:585-591.
41. Strísovský K, Jirásková J, Mikulová A, Rulísek L, Konvalinka J. 2005. Dual substrate and reaction specificity in mouse serine racemase: identification of high-affinity dicarboxylate substrate and inhibitors and analysis of the beta-eliminase activity. Biochemistry 44:13091-13100.
42. Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J, Oberheim N, Lou N, Wang X, Zielke HR, Kang J, Nedergaard M. 2005. An astrocytic basis of epilepsy. Nat Med 11:973-981.
43. Tingley WG, Ehlers MD, Kameyama K, Doherty C, Ptak JB, Riley CT, Huganir RL. 1997. Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J Biol Chem 272:5157-5166.
44. Williams SM, Diaz CM, Macnab LT, Sullivan RK, Pow DV. 2006. Immunocytochemical analysis of D-serine distribution in the mammalian brain reveals novel anatomical compartmentalizations in glia and neurons. Glia 53:401-411. (Pubitemid 43294750)
45. Willoughby JO, Mackenzie L, Broberg M, Thoren AE, Medvedev A, Nilsson M. 2003. Fluorocitrate-mediated astroglia dysfunction causes seizures. J Neurosci Res 74:160-166. (Pubitemid 37176679)
46. Wood PL, Emmett MR, Rao TS, Mick S, Cler J, Iyengar S. 1989. In vivo modulation of the N-methyl-D-aspartate receptor complex by D-serine: potentiation of ongoing neuronal activity as evidenced by increased cerebellar cyclic GMP. J Neurochem 53:979-981.
47. Wu K, Leung LS. 2003. Increased dendritic excitability in hippocampal CA1 in vivo in the kainic acid model of temporal lobe epilepsy: a study using current source density analysis. Neuroscience 116:599-616.
48. Wu SZ, Bodles AM, Porter MM, Griffin WS, Basile AS, Barger SW. 2004. Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide. J Neuroinflamm 1:2.
49. Yoshikawa M, Nakajima K, Takayasu N, Noda S, Sato Y, Kawaguchi M, Oka T, Kobayashi H, Hashimoto A. 2006. Expression of the mRNA and protein of serine racemase in primary cultures of rat neurons. Eur J Pharmacol 548:74-76.
50. Zheng X, Zhang L, Wang AP, Bennett MV, Zukin RS. 1999. Protein kinase C potentiation of N-methyl-D-aspartate receptor activity is not mediated by phosphorylation of N-methyl-D-aspartate receptor subunits. Proc Natl Acad Sci U S A 96:15262-15267.